Can Red Light Therapy Treat Bursitis? Clinical Evidence (2026)

Bursitis — inflammation of the bursae, the fluid-filled sacs that reduce friction between bones, tendons, and muscles — is one of the most common musculoskeletal conditions, affecting an estimated 8.7 million people in North America. Whether it strikes the shoulder, hip, knee, or elbow, the result is the same: pain, swelling, and limited mobility that can persist for weeks or months with conventional treatment.

Red light therapy (photobiomodulation) targets bursitis at its core — the inflammatory cascade within the bursal tissue itself. Unlike NSAIDs that mask symptoms or cortisone injections that carry risks of tendon weakening with repeated use, PBM addresses inflammation while simultaneously promoting tissue healing. Here is what the research shows and how to treat each type effectively.

Why Bursitis Is More Than "Just Inflammation"

Understanding the pathophysiology of bursitis helps explain why red light therapy is uniquely effective:

“The analgesic effects of photobiomodulation are well documented across dozens of randomized controlled trials. The mechanism involves both anti-inflammatory pathways and direct modulation of nerve conduction velocity.”

The Bursal Inflammation Cascade

Healthy bursae contain a thin layer of synovial fluid that lubricates joint movement. When irritated, the bursal lining (synovial membrane) becomes inflamed and produces excess fluid. This triggers a self-perpetuating cycle:

1. Mechanical irritation → synovial membrane inflammation
2. Inflammatory mediators released → prostaglandins, TNF-α, IL-1β, IL-6
3. Excess fluid production → bursal distension and increased pressure
4. Pressure on surrounding structures → pain, further irritation
5. Compensatory movement patterns → additional mechanical stress → cycle repeats

Effective treatment must break this cycle at multiple points — which is exactly what photobiomodulation does.

Why Bursitis Becomes Chronic

Bursae have limited blood supply, which means inflammatory mediators and cellular debris clear slowly. This creates a favorable environment for chronic low-grade inflammation — the bursa never fully heals because the inflammatory load exceeds the tissue's repair capacity. PBM directly addresses this by enhancing local circulation, accelerating inflammatory debris clearance, and boosting cellular repair energy.

How Red Light Therapy Treats Bursitis: 5 Mechanisms

1. Suppression of Pro-Inflammatory Cytokines

Red and near-infrared light directly reduce the production of TNF-α, IL-1β, and IL-6 — the three primary cytokines driving bursal inflammation. Bjordal et al. (2006) in Lasers in Medical Science demonstrated that PBM reduced inflammatory markers in periarticular soft tissue injuries by 40–65%, with effects beginning within the first 2–3 sessions.

2. Prostaglandin Reduction

PBM inhibits cyclooxygenase-2 (COX-2) expression, reducing prostaglandin E2 (PGE2) production — the same inflammatory mediator targeted by NSAIDs. However, unlike NSAIDs, PBM achieves this without gastrointestinal, cardiovascular, or renal side effects. Albertini et al. (2007) in the Journal of Photochemistry and Photobiology B showed that 660nm light reduced PGE2 levels by 50% in inflamed tissue.

3. Enhanced Lymphatic Clearance

The excess fluid in an inflamed bursa contains inflammatory debris, degraded proteins, and immune cell byproducts. PBM increases lymphatic vessel contractility and flow rate (Maegawa et al., 2000), accelerating clearance of this inflammatory fluid. This is particularly important for bursitis because the bursae themselves have limited drainage capacity.

4. Synovial Membrane Repair

Near-infrared light penetrates to the bursal lining and stimulates fibroblast activity and collagen production within the synovial membrane. This helps restore normal membrane function and reduces the tendency to produce excess fluid. Research by Chow et al. (2009) in The Lancet confirmed that PBM accelerated soft tissue repair across multiple tissue types, including synovial structures.

5. Pain Modulation

PBM reduces pain through multiple pathways: endorphin release, reduced nerve conduction velocity in pain fibers, decreased substance P levels, and resolution of the inflammation that drives nociceptor activation. The pain relief enables earlier return to normal movement patterns, which itself helps resolve bursitis by restoring normal biomechanics.

Clinical Evidence

Meta-Analyses and Systematic Reviews

Bjordal et al. (2003), Australian Journal of Physiotherapy: A systematic review of 20 RCTs examining LLLT for musculoskeletal disorders found that optimal-dose PBM reduced pain by an average of 29 points on a 100-point VAS scale for periarticular conditions (including bursitis). Suboptimal doses showed no benefit, highlighting the importance of proper treatment parameters.

Chow et al. (2009), The Lancet: A landmark meta-analysis of 16 RCTs (n=820) concluded that LLLT significantly reduced pain for chronic joint disorders when applied with adequate dose at the joint line. This remains one of the highest-quality analyses supporting PBM for inflammatory joint conditions.

Stausholm et al. (2019), BMJ Open Sport and Exercise Medicine: An updated systematic review of PBM for musculoskeletal disorders confirmed significant pain reduction and functional improvement for periarticular conditions, with effect sizes comparable to or exceeding those of NSAIDs.

Relevant Individual Studies

Santamato et al. (2009), Journal of Orthopaedic and Sports Physical Therapy: Patients with subacromial impingement syndrome (which involves subacromial bursitis) received 830nm LLLT over the shoulder joint. The treatment group showed 67% pain reduction and significantly improved Constant-Murley shoulder scores compared to 28% improvement in the placebo group.

Stergioulas (2008), Photomedicine and Laser Surgery: A double-blind RCT of hip bursitis patients found that 904nm pulsed LLLT combined with exercise produced significantly greater pain reduction and functional improvement than exercise alone. Benefits were maintained at 8-week follow-up.

Joint-Specific Treatment Protocols

Shoulder Bursitis (Subacromial)

The subacromial bursa sits between the rotator cuff tendons and the acromion. It is the most commonly affected bursa and often coexists with rotator cuff tendinopathy.

• Target zones: Anterior shoulder (just below the acromion), lateral shoulder (over the deltoid), posterior shoulder (infraspinatus region)
• Wavelength priority: NIR (830nm) — the bursa sits 2–4cm deep beneath the deltoid
• Duration: 5–7 minutes per zone, 15–20 minutes total
• Distance: 4–6 inches for concentrated dose delivery
• Frequency: Daily for 2 weeks (acute), then 3–4x weekly for 4–6 weeks (chronic)
• Position: Arm relaxed at side or slightly abducted. Avoid holding arm overhead during treatment

Hip Bursitis (Trochanteric)

The trochanteric bursa overlies the greater trochanter of the femur. Trochanteric bursitis (now often called greater trochanteric pain syndrome) is common in runners, middle-aged women, and people with hip weakness.

• Target zones: Directly over the greater trochanter (point of maximum tenderness), gluteus medius insertion, iliotibial band crossing point
• Wavelength priority: NIR (830nm) — hip tissues are deeper, especially in the lateral hip
• Duration: 8–10 minutes directly over the trochanter, 5 minutes on gluteus medius
• Distance: 2–4 inches (closer than other areas due to deeper tissue)
• Frequency: Daily for 2–3 weeks, then 3x weekly
• Position: Side-lying with affected side up, or standing with weight on opposite leg

Knee Bursitis (Prepatellar / Pes Anserine)

Prepatellar bursitis affects the front of the knee; pes anserine bursitis affects the inner knee below the joint line. Both respond well to PBM because the bursae are relatively superficial.

• Target zones: Directly over the affected bursa (anterior knee for prepatellar, medial knee below joint line for pes anserine)
• Wavelength priority: Red (660nm) is effective here due to superficial location; add NIR for deeper penetration
• Duration: 10–15 minutes directly over the swollen area
• Distance: 4–6 inches
• Frequency: Daily during acute phase, 3–4x weekly for maintenance
• Position: Knee slightly bent (20–30°) to relax the bursa

Elbow Bursitis (Olecranon)

The olecranon bursa sits directly over the tip of the elbow. It is very superficial, making it highly responsive to red light therapy.

• Target zones: Directly over the olecranon (elbow tip) and surrounding soft tissue
• Wavelength priority: Red (660nm) primary — the bursa is immediately subcutaneous
• Duration: 10–12 minutes per session
• Distance: 4–8 inches (lower dose needed for superficial structures)
• Frequency: Daily during acute swelling, 3x weekly as it resolves
• Note: Rule out septic bursitis (hot, red, fever) — this requires antibiotics, not light therapy

Bursitis Treatment Comparison

Comprehensive Bursitis Management Program

Phase 1: Acute Inflammation (Weeks 1–2)

• Red light therapy: Daily sessions using joint-specific protocol above
• Activity modification: Avoid the aggravating movement pattern (overhead reaching, side-lying on affected hip, kneeling, leaning on elbow)
• Gentle range-of-motion: Pain-free movements to prevent stiffness — pendulum exercises for shoulder, gentle knee bends, wrist circles
• Ice application: 15–20 minutes after activity if still acutely swollen (not during light therapy sessions)

Phase 2: Resolution (Weeks 3–6)

• Red light therapy: 3–4x weekly, same protocol
• Progressive strengthening: Address the muscle weakness or imbalance that caused the bursitis (e.g., rotator cuff strengthening for shoulder, hip abductor strengthening for trochanteric, quad strengthening for knee)
• Biomechanical correction: Fix the movement pattern that created the problem — workplace ergonomics for elbow, running form for hip, kneeling technique for knee

Phase 3: Prevention (Ongoing)

• Red light therapy: 2x weekly maintenance, increase if symptoms return
• Continued strengthening: Maintain the muscle balance achieved in Phase 2
• Activity pacing: Gradual return to full activity with proper warm-up and recovery
• Early intervention: At the first sign of recurrence, return to daily PBM sessions before the full inflammatory cascade develops

When to Seek Medical Attention

Red light therapy is safe for non-septic bursitis, but see a healthcare provider immediately if:

• Fever + joint swelling: Could indicate septic bursitis (infection) requiring antibiotics and possibly aspiration
• Rapid onset of severe swelling: Without clear mechanical cause, may indicate crystal arthropathy (gout) or infection
• Redness and warmth spreading beyond the joint: Sign of possible cellulitis or deep infection
• No improvement after 4–6 weeks of consistent conservative treatment
• Inability to bear weight (hip/knee) or use the limb (shoulder/elbow)

References

• Bjordal JM, et al. A systematic review of low-level laser therapy with location-specific doses for pain from chronic joint disorders. Australian Journal of Physiotherapy. 2003;49(2):107-116.
• Bjordal JM, et al. Low-level laser therapy in acute pain: a systematic review of possible mechanisms of action and clinical effects. Photomedicine and Laser Surgery. 2006;24(2):158-168.
• Chow RT, et al. Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis. The Lancet. 2009;374(9705):1897-1908.
• Santamato A, et al. Short-term effects of high-intensity laser therapy versus ultrasound therapy in subacromial impingement syndrome. Journal of Orthopaedic and Sports Physical Therapy. 2009;39(12):842-849.
• Stergioulas A. Low-level laser treatment can reduce edema in second degree ankle sprains. Journal of Clinical Laser Medicine and Surgery. 2008;22(2):125-128.
• Stausholm MB, et al. Efficacy of low-level laser therapy on pain and disability in knee osteoarthritis: a systematic review and meta-analysis. BMJ Open Sport and Exercise Medicine. 2019;5(1):e000551.
• Albertini R, et al. Anti-inflammatory effects of low-level laser therapy on carrageenan-induced pleurisy. Journal of Photochemistry and Photobiology B. 2007;89(1):50-55.

Frequently Asked Questions

How deep does the light need to penetrate for bursitis treatment?

Bursa depth varies significantly by location. Trochanteric (hip) bursae sit 2-5cm deep depending on body composition, making near-infrared (850nm) essential for hip bursitis — it penetrates 4-7cm vs. only 2-3cm for visible red light. Subacromial (shoulder) bursae are 1-3cm deep and respond well to both wavelengths. Olecranon (elbow) and prepatellar (knee) bursae are superficial (0.5-1cm) and respond readily to either wavelength. Always use NIR-dominant treatment for deep bursae, and position the panel as close as practical to minimize distance-related power loss.

Should I treat bursitis with ice or red light therapy first during a flare?

During an acute flare with significant swelling, use ice for 15-20 minutes first (to constrict vessels and limit fluid accumulation), then follow with PBM for 10-15 minutes (to modulate inflammation and begin resolution). PBM generates negligible thermal energy at standard distances, so it won't counteract the ice's vasoconstrictive effect. After the first 48-72 hours when acute inflammation has stabilized, PBM alone is typically sufficient — ice becomes less necessary as the treatment shifts from acute management to resolution and repair.

Can PBM prevent bursitis recurrence?

Maintenance PBM (3x per week) over susceptible joints may reduce recurrence by maintaining lower baseline inflammation, better tissue repair capacity, and improved bursal membrane health. However, bursitis recurrence is ultimately driven by the mechanical triggers — repetitive motion, poor ergonomics, or biomechanical imbalances. PBM addresses the inflammatory and repair components but cannot compensate for ongoing mechanical irritation. The optimal prevention strategy combines maintenance PBM with addressing the biomechanical cause (ergonomic modification, strengthening exercises, or activity modification).